Cargando…
Moving Branded Statins to Lowest Copay Tier Improves Patient Adherence
BACKGROUND: Statins are efficacious in reducing the risk of major cardiovascular events for both primary and secondary prevention, yet long-term adherence is poor. Their effectiveness could be compromised in actual practice when patients are not adherent to the treatments. Higher copayments have bee...
Autores principales: | Chen, Shih-Yin, Shah, Sonali N., Lee, Yuan-Chi, Boulanger, Luke, Mardekian, Jack, Kuznik, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437520/ https://www.ncbi.nlm.nih.gov/pubmed/24372458 http://dx.doi.org/10.18553/jmcp.2014.20.1.34 |
Ejemplares similares
-
Effect of electronic prescribing with formulary decision support on medication tier, copayments, and adherence
por: Pevnick, Joshua M, et al.
Publicado: (2014) -
Unraveling the Effects of Tier-Copayment Drug Benefit Designs
por: Curtiss, Frederic R.
Publicado: (2003) -
Association of Copayment with Likelihood and Level of Adherence in New Users of Statins: A Retrospective Cohort Study
por: Watanabe, Jonathan H., et al.
Publicado: (2014) -
Hypertension, Prescription Drug Copayments, and Drug Therapy Adherence
por: Curtiss, Frederic R.
Publicado: (2003) -
Association Between Copayment and Adherence to Medications for Pulmonary Arterial Hypertension
por: Schikowski, Erin M., et al.
Publicado: (2022)